CH666481A5 - 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn. - Google Patents

4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn. Download PDF

Info

Publication number
CH666481A5
CH666481A5 CH202386A CH202386A CH666481A5 CH 666481 A5 CH666481 A5 CH 666481A5 CH 202386 A CH202386 A CH 202386A CH 202386 A CH202386 A CH 202386A CH 666481 A5 CH666481 A5 CH 666481A5
Authority
CH
Switzerland
Prior art keywords
hydroxy
oxo
acetic acid
alkyl
anhydrous
Prior art date
Application number
CH202386A
Other languages
German (de)
Inventor
Thomas Dr Meul
Garrity John Dr Mc
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Priority to CH202386A priority Critical patent/CH666481A5/en
Priority to IL80071A priority patent/IL80071A0/en
Priority to EP86112952A priority patent/EP0216325A3/en
Priority to NO863769A priority patent/NO863769L/en
Priority to ES8602069A priority patent/ES2001696A6/en
Priority to DK453586A priority patent/DK453586A/en
Priority to HU864071A priority patent/HUT43039A/en
Priority to CS87617A priority patent/CS257300B2/en
Priority to US07/188,702 priority patent/US4824966A/en
Publication of CH666481A5 publication Critical patent/CH666481A5/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones

Abstract

Prodn. of 4-hydroxy-2-oxo-1 -pyrrolidinylacetamide (I) is effected by (a) treating an alkyl 4-alkoxy-2-oxo -3-pyrroline-1-acetate of formula (II) either with an anhydrous acid or with MeSiCl3 in the presence of an alkali metal iodide to form an alkyl 2,4-dioxo-1 -pyrrolidinylacetate (III); (b) reducing (III) with NaBH4 to form an alkyl 4-hydroxy-2-oxo-1-pyrrolidinylacetate (IV); and (c) reacting (IV) with NH3c. In thormulae R1 = Me or Et; R2 = 1-4C alkyl. Pref. step (a) is effected with MeSiCl3 and NaI in MeCN or with HCl gas in anhydrous HOAc.

Description

       

  
 



   BESCHREIBUNG



   Die Erfindung betrifft ein neues Verfahren zur Herstellung des cerebral wirksamen 4-Hydroxy-2-oxo-pyrrolidin-1yl-acetamids. Es sind Verfahren zur Herstellung des obengenannten Wirkstoffes bekannt. Schlechte Ausbeuten und teure Ausgangsprodukte machen die Verfahren jedoch nicht rentabel.



   Es stellt sich daher die Aufgabe, einen Weg zu finden, der die genannten Nachteile ausschaltet.



   Gelöst wurde die Aufgabe erfindungsgemäss durch ein
Verfahren nach Anspruch 1. Darin wird ein   4-(C1C2)-alk-       oxy-3-pyrrolin-2-on- 1 -yl-essigsäure-(C1-C4)-alkylester,    vor zugsweise   4- Methoxy-3-pyrrolin-2-on-    1 -yl-essigsäureethyl ester in saurem wasserfreien Medium umgesetzt.



   Das saure Medium wird zweckmässig durch Einleiten von gasförmiger Salzsäure oder gasförmigem Bromwasser stoff, in eine   C,-C4-Carbonsäure,    die ebenfalls wasserfrei ist, erzeugt.



   Bevorzugte   Cl-C4-Carbonsäure    ist die Essigsäure. Beson ders bevorzugt wird Salzsäure in Essigsäure verwendet.



   Die Umsetzungstemperatur wählt man zweckmässig zwi schen 0 und 50   C.   



   Nach einer Reaktionszeit von 5 bis 10 Stunden kann das
Reaktionsgemisch auf übliche Weise durch z.B. Abdampfen des Lösungsmittels und gegebenenfalls durch Kristallisation aufgearbeitet werden.



   Die Überführung der   2,4-Dioxo-pyrrolidin-l -yl-essigsäu-      re-(C1-C4)-alkylester,    speziell des Ethylesters, in das Zielmolekül   4-Hydroxy-2-oxo-pyrrolidin- 1 -yl-acetamid    durch Reduktion mit Natriumborhydrid und nachfolgende Amidierung mit Ammoniak wurde in der Literatur bereits vorexerziert.



   (G. Pifferi, M. Pinza, JI Farmaco, Ed.Sc.,1977, 32, 602.)
Das   4-Hydroxy-2-oxo-pyrrolidin-1-yl-acetamid    kann danach als reines weisses Produkt in guter Ausbeute erhalten werden.



   Beispiel Herstellung von   2,4-Dioxo-pyrroldin-l-yl-essgsäureethylester   
10,0 g 4-Methoxy-3-pyrrolin-2-on- 1 -yl-essigsäureethylester (GC-Gehalt: 80%) wurden in 50,0 ml Essigsäure gelöst und bei 35 bis 40   "C    9 Stunden unter Rühren mit gasförmiger Salzsäure gesättigt. Anschliessend wurde die Essigsäure am Rotationsverdampfer unter Vakuum bei einer Badetemperatur von 60   "C    eingedampft. Der Rückstand wurde in 50,0 ml Toluol aufgenommen und nochmals eingedampft.



  Als Rückstand verblieben 12,4 g Rohprodukt, das im Kühlschrank kristallisierte.



  Herstellung von   4-Hydroxy-%oxo-pyrrollei'i-1-yl-essigsäu-    reethylester
12,2 g des oben erhaltenen Rohproduktes wurden in 50,0 ml Acetonitril gelöst und bei Raumtemperatur zu einer Suspension von 1,6 g Natriumborhydrid in 50,0 ml Acetonitril gegeben. Dabei stieg die Reaktionstemperatur auf 35 bis 40   "C.    Bei dieser Temperatur wurde die Reaktionslösung eine Stunde nachgerührt. Anschliessend wurde mit konzentrierter Salzsäure angesäuert auf einen pH von ca. 5. Das Lösungsmittel wurde am Rotationsverdampfer eingeengt, der Rückstand mit 25,0 ml Eiswasser versetzt und mit Methylenchlorid extrahiert. Nach Trocknen der Methylenchlorid-Lösung über Natriumsulfat und Eindampfen des Lösungsmittels verblieben 9,5 g Rohprodukt mit einem Gehalt nach HPLC von 51,5%.

  Dies entsprach einer Ausbeute von   66,1 %    bezogen auf eingesetztes 4-Methoxy-3-pyrrolin-2-on1 -yl-essigsäureethylester.

 

   Chromatographische Filtration über Kieselgel mit Essigester als Laufmittel ergab ein Produkt mit einem Gehalt von grösser 96% (HPLC).



  Herstellung von   4-Hydoxy-2-oxo-pyrrolidin-l-yl-acetamid   
13,7 g (73 mmol)   4-Hydroxy-2-oxo-pyrrolidin-1-yl-essig-    säureethylester wurden gelöst in 500 ml Methanol und bei   O      "C    mit Ammoniak gesättigt. Danach wurde während einer Stunden bei Raumtemperatur gehalten. Abdampfen des Lösungsmittels unter Vakuum führte zu einem festen Rückstand. Dieser wurde in Methanol kristallisiert.



   Es resultierten 7,17 g (62%) des Produktes in Form eines weissen Pulvers. Fp 165 bis 168   "C.   



   IR (Nujol) 3400   cm-l,    3250   cm-l    (OH und NH) 1660   cm-l    (C=O). 



  
 



   DESCRIPTION



   The invention relates to a new process for producing the cerebrally active 4-hydroxy-2-oxopyrrolidin-1yl-acetamide. Processes for producing the above-mentioned active ingredient are known. However, poor yields and expensive starting products do not make the processes profitable.



   The task is therefore to find a way that eliminates the disadvantages mentioned.



   According to the invention, the object was achieved by a
A method according to claim 1. Therein is a 4- (C1C2) alkoxy-3-pyrrolin-2-one-1-yl-acetic acid (C1-C4) alkyl ester, preferably 4-methoxy-3-pyrroline 2-one-1-ethyl acetate in an acidic anhydrous medium.



   The acidic medium is conveniently generated by introducing gaseous hydrochloric acid or gaseous hydrogen bromide into a C, -C4 carboxylic acid, which is also anhydrous.



   The preferred Cl-C4 carboxylic acid is acetic acid. Hydrochloric acid in acetic acid is particularly preferred.



   The reaction temperature is suitably chosen between 0 and 50 C.



   After a reaction time of 5 to 10 hours, it can
Reaction mixture in the usual way by e.g. Evaporation of the solvent and optionally worked up by crystallization.



   The conversion of the 2,4-dioxopyrrolidin-l -yl-acetic acid (C1-C4) alkyl ester, especially the ethyl ester, into the target molecule 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide Reduction with sodium borohydride and subsequent amidation with ammonia has already been pre-practiced in the literature.



   (G. Pifferi, M. Pinza, JI Farmaco, Ed.Sc., 1977, 32, 602.)
The 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide can then be obtained as a pure white product in good yield.



   Example Preparation of 2,4-Dioxo-pyrroldin-l-yl-ethyl acetate
10.0 g of 4-methoxy-3-pyrrolin-2-one-1-ethyl acetate (GC content: 80%) were dissolved in 50.0 ml of acetic acid and at 35 to 40 "C for 9 hours with stirring with gaseous The acetic acid was then evaporated on a rotary evaporator under vacuum at a bath temperature of 60 ° C. The residue was taken up in 50.0 ml of toluene and evaporated again.



  12.4 g of crude product remained as residue, which crystallized in the refrigerator.



  Production of 4-hydroxy-% oxopyrolli'i-1-yl-acetic acid ethyl ester
12.2 g of the crude product obtained above were dissolved in 50.0 ml of acetonitrile and added to a suspension of 1.6 g of sodium borohydride in 50.0 ml of acetonitrile at room temperature. The reaction temperature rose to 35 to 40 ° C. At this temperature, the reaction solution was stirred for an hour. The mixture was then acidified to a pH of about 5 with concentrated hydrochloric acid. The solvent was concentrated on a rotary evaporator, the residue with 25.0 ml of ice water After drying the methylene chloride solution over sodium sulfate and evaporating the solvent, 9.5 g of crude product with a content by HPLC of 51.5% remained.

  This corresponded to a yield of 66.1% based on the 4-methoxy-3-pyrrolin-2-on1-yl ethyl acetate used.

 

   Chromatographic filtration over silica gel with ethyl acetate as the eluent gave a product with a content of greater than 96% (HPLC).



  Preparation of 4-Hydoxy-2-oxo-pyrrolidin-l-yl-acetamide
13.7 g (73 mmol) of 4-hydroxy-2-oxopyrrolidin-1-yl-acetic acid ethyl ester were dissolved in 500 ml of methanol and saturated with ammonia at 0 "C. Thereafter, the mixture was kept at room temperature for one hour. Evaporation the solvent in vacuo gave a solid residue which was crystallized in methanol.



   7.17 g (62%) of the product resulted in the form of a white powder. Mp 165 to 168 "C.



   IR (Nujol) 3400 cm-l, 3250 cm-l (OH and NH) 1660 cm-l (C = O).


    

Claims (4)

PATENTANSPRÜCHE 1. Verfahren zu Herstellung von 4-Hydroxy-2-oxo-pyrro lid in- 1 -yl-acetamid, dadurch gekennzeichnet, dass man (C C2)-alkoxy-3-pyrrolin-2-on- 1 -yl-essigsäure-4-(C 1-C4)-alkyl- ester der Formel EMI1.1 worin R1 = Alkyl mit 1 bis 2 C-Atomen und R2 = Alkyl mit 1 bis 4 C-Atomen bedeutet, in saurem wasserfreien Medium zum 2,4-Dioxo-pyrrolidin- 1 -yl-essigsäure-(C1-C4)-alkylester umsetzt, diesen ohne zu isolieren mit Natriumborhydrid zu einem 4-Hydroxy-2-oxo-pyrrolidin-1-yl-essigsäure-C-C4-al- kylester hydriert und schliesslich durch Amidierung mittels Ammoniak den 4-Hydroxy-2-oxo-pyrrolidin- 1 -yl-essigsäure- Cl-C4-alkylester in das gewünschte Endprodukt überführt.  PATENT CLAIMS 1. A process for the preparation of 4-hydroxy-2-oxo-pyrrolide in 1-yl-acetamide, characterized in that (C C2) -alkoxy-3-pyrrolin-2-one-1-yl-acetic acid 4- (C 1 -C 4) alkyl esters of the formula EMI1.1  wherein R1 = alkyl with 1 to 2 carbon atoms and R2 = alkyl with 1 to 4 carbon atoms, in acidic anhydrous medium to the 2,4-dioxopyrrolidin-1-yl-acetic acid (C1-C4) alkyl ester reacted, without isolating with sodium borohydride to a 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetic acid-C4-C4-alkyl ester, and finally by amidation with ammonia the 4-hydroxy-2-oxo-pyrrolidine - 1 -yl-acetic acid- Cl-C4-alkyl ester converted into the desired end product.   2. Verfahren nach Patentanspruch 1, dadurch gekennzeichnet. dass das saure wasserfreie Medium durch Einleiten von gasförmiger Salzsäure oder gasförmigem Bromwasserstoff in eine wasserfreie C1-C4-Carbonsäure erzeugt wird.  2. The method according to claim 1, characterized. that the acidic anhydrous medium is generated by introducing gaseous hydrochloric acid or gaseous hydrogen bromide into an anhydrous C1-C4 carboxylic acid. 3. Verfahren nach Patentanspruch 2, dadurch gekennzeichnet, dass als wasserfreie C1-C4-Carbonsäure Essigsäure verwendet wird.  3. The method according to claim 2, characterized in that acetic acid is used as the anhydrous C1-C4 carboxylic acid. 4. Verfahren nach Patentansprüchen 2 und 3, dadurch gekennzeichnet, dass mit gasförmiger Salzsäure in wasserfreier Essigsäure gearbeitet wird.  4. The method according to claims 2 and 3, characterized in that one works with gaseous hydrochloric acid in anhydrous acetic acid.
CH202386A 1985-09-24 1986-05-20 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn. CH666481A5 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
CH202386A CH666481A5 (en) 1986-05-20 1986-05-20 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.
IL80071A IL80071A0 (en) 1985-09-24 1986-09-17 Pyrrolidine acetamide derivatives
EP86112952A EP0216325A3 (en) 1985-09-24 1986-09-19 Process for the preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
NO863769A NO863769L (en) 1985-09-24 1986-09-22 PROCEDURE FOR THE PREPARATION OF 4-HYDROXY-2-OXOPYRROLIN-1-YL-ACETAMIDE.
ES8602069A ES2001696A6 (en) 1985-09-24 1986-09-22 Process for the preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide.
DK453586A DK453586A (en) 1985-09-24 1986-09-23 METHOD OF PREPARING 4-HYDROXY-2-OXO-PYRROLIDIN-1-YL-ACETAMIDE
HU864071A HUT43039A (en) 1985-09-24 1986-09-24 Process for preparing 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
CS87617A CS257300B2 (en) 1986-05-20 1987-01-30 Production method of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
US07/188,702 US4824966A (en) 1985-09-24 1988-05-04 Process for the production of 4-hydroxy-2-oxo-pyrrolidin-1-yl acetamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH202386A CH666481A5 (en) 1986-05-20 1986-05-20 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.

Publications (1)

Publication Number Publication Date
CH666481A5 true CH666481A5 (en) 1988-07-29

Family

ID=4224104

Family Applications (1)

Application Number Title Priority Date Filing Date
CH202386A CH666481A5 (en) 1985-09-24 1986-05-20 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.

Country Status (1)

Country Link
CH (1) CH666481A5 (en)

Similar Documents

Publication Publication Date Title
NO151876B (en) PROCEDURE AND APPARATUS FOR ANIMAL LINING
DE2519063A1 (en) PROCESS FOR MANUFACTURING ADENIN DERIVATIVES
EP0045910B1 (en) Indole derivatives and process for their production
DE2227011C2 (en) Process for the splitting of DL-phenylglycine esters into the optical isomers
DE2903891C2 (en)
CH412889A (en) Process for the preparation of 2-methyl-3-oxypyridines
EP0252353B1 (en) 4-benzyloxy-3-pyrrolin-2-one-1-yl-acetamide, preparation and use
DE19600034C2 (en) 1,1,2-Trisubstituted cyclopropane compounds, process for their preparation and dihydroxyethyl-substituted 1-amino-cyclopropane-1-carboxylic acid
CH666481A5 (en) 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.
EP0202625B1 (en) Process for the preparation of 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-beta-(n-benzyl-n-methylamino)-ethyl ester 5-methyl ester and its hydrochloride salt
EP0216325A2 (en) Process for the preparation of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide
EP0600460A1 (en) Process for the preparation of 6(S)-5,6,7,8-tetrahydrofolic acid
DE3338832C2 (en)
DE2828888C2 (en)
DE69822222T2 (en) PROCESS FOR PREPARING BETA-HYDROXY-GAMMA-BUTYROLACTONE DERIVATIVES AND BETA- (METH) ACRYLOXY-GAMMA-BUTYROLACTONE DERIVATIVES
DE2707404C3 (en) Process for the preparation of 5,6-dehydropenicillins
DE10019291C2 (en) 2-alkoxy-5-methoxypyrimidines or their tautomeric forms and processes for their preparation
DE3639583C2 (en)
EP0087657B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid
EP0087654B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid
CH664957A5 (en) 4-Hydroxy-2-oxo-1-pyrrolidinyl-acetamide prodn.
EP0548895A2 (en) Process for the preparation of pure diasteroisomers of tetrahydrofolates
DE2433176A1 (en) 2-Halopyrimidine derivs - prepd. from cyanoimino acetates via N-cyano cyanoimino acetates
EP0029117A1 (en) 10-Bromosandwicine and 10-bromoisosandwicine, as well as their additions salts with pharmacolical acceptable acids process for their preparation and their use
DE1643012C3 (en) Process for the preparation of butenolides

Legal Events

Date Code Title Description
PL Patent ceased